• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气管内吸出物微观质量对重症监护病房疑似下呼吸道感染患者使用Filmarray®肺炎加检测板检测结果的影响

Impact of the microscopic quality of endotracheal aspirates on the performance of the Filmarray® pneumonia plus panel in intensive care unit patients with suspected lower respiratory tract infection.

作者信息

Cano Sofía, de Michelena Paula, Clari Mª Ángeles, Liñan Jorge, Olea Beatriz, Torres Ignacio, Carbonell Nieves, Navarro David

机构信息

Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia, 46010, Spain.

Medical Intensive Care Unit, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.

出版信息

Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):27-35. doi: 10.1007/s10096-024-04967-9. Epub 2024 Oct 28.

DOI:10.1007/s10096-024-04967-9
PMID:39466545
Abstract

PURPOSE

We investigated how the microscopic quality of endotracheal aspirates (ETA) impacts the performance of the Filmarray® pneumonia plus panel (FA-PP) in patients undergoing mechanical ventilation (IMV) with suspicion of lower respiratory tract bacterial infection (LRTBI).

METHODS

The quality of ETA was categorized according to the number of leukocytes and buccal squamous epithelial (BSE)/field (100x magnification). G5 (< 10 BSE cells and > 25 leukocytes/field) and G4 (10-25 BSE cells and > 25 leukocytes/field) ETA were tested in parallel by the FA-PP and conventional semiquantitative culture.

RESULTS

In total, 153 ETA were graded as G5 (from 115 patients) and 56 as G4 (from 48 patients). Focusing on "conventional" bacterial species, a trend towards more positive results (P = 0.16), and co-detections (P = 0.18) was returned by G5 ETA. Although more targets were detected on G5 ETA (P = 0.005), the spectra of bacteria detected was comparable across G5 and G4 specimens. A trend towards higher bacterial burdens as quantitated by the FA-PP, and irrespective of the target, was observed in G5 (median, 10 genome copies/ml) vs. G4 ETA (median, 10 genome copies/ml). The degree of full agreement between FA-PP and culture was higher for G5 ETA (Kappa value, 0.54; 95% CI, 0.43-0.66) than for G4 ETA (Kappa value, 0.31; 95% CI, 0.11-0.49). For all bacterial targets detected, genome copy/ml numbers exceeded colony forming units (CFU)/ml counts in 1-2 log, irrespective of ETA grading. The degree of correlation between genome copies/ml and CFU/ml was slightly better for G5 ETA (Rho = 0.65; P = 0.001) than for G4 ETA (Rho = 0.54; P = 0.11).

CONCLUSION

FA-PP testing of G5 ETA may provide more comprehensive and clinically useful information compared with G4 specimens in patients undergoing IMV with suspected LRTBI and receiving antimicrobial therapy. Yet G4 ETA may still provide useful microbiological information.

摘要

目的

我们研究了气管内吸出物(ETA)的微观质量如何影响疑似下呼吸道细菌感染(LRTBI)的机械通气(IMV)患者中Filmarray®肺炎加检测板(FA-PP)的性能。

方法

根据白细胞数量和颊鳞状上皮(BSE)/视野(100倍放大)对ETA质量进行分类。通过FA-PP和传统半定量培养对G5(<10个BSE细胞且>25个白细胞/视野)和G4(10-25个BSE细胞且>25个白细胞/视野)的ETA进行平行检测。

结果

总共153份ETA被评为G5(来自115名患者),56份被评为G4(来自48名患者)。聚焦于“传统”细菌种类,G5的ETA有更阳性结果(P = 0.16)和共同检测结果(P = 0.18)的趋势。尽管在G5的ETA上检测到更多靶点(P = 0.005),但G5和G4标本中检测到的细菌谱相当。在G5(中位数,10个基因组拷贝/ml)与G4的ETA(中位数,10个基因组拷贝/ml)中,观察到FA-PP定量的细菌载量有升高趋势,且与靶点无关。G5的ETA中FA-PP与培养之间的完全一致性程度(Kappa值,0.54;95%CI,0.43-0.66)高于G4的ETA(Kappa值,0.31;95%CI,0.11-0.49)。对于所有检测到的细菌靶点,无论ETA分级如何,基因组拷贝/ml数比菌落形成单位(CFU)/ml计数超出1-2个对数。G5的ETA中基因组拷贝/ml与CFU/ml之间的相关性程度(Rho = 0.65;P = 0.001)略优于G4的ETA(Rho = 0.54;P = 0.11)。

结论

对于疑似LRTBI并接受抗菌治疗的IMV患者,与G4标本相比,G5的ETA进行FA-PP检测可能提供更全面且临床有用的信息。然而,G4的ETA仍可能提供有用的微生物学信息。

相似文献

1
Impact of the microscopic quality of endotracheal aspirates on the performance of the Filmarray® pneumonia plus panel in intensive care unit patients with suspected lower respiratory tract infection.气管内吸出物微观质量对重症监护病房疑似下呼吸道感染患者使用Filmarray®肺炎加检测板检测结果的影响
Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):27-35. doi: 10.1007/s10096-024-04967-9. Epub 2024 Oct 28.
2
Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.用于鉴定重症监护病房成年患者下呼吸道标本中呼吸道病原体和主要耐药决定因素的多重 PCR 肺炎检测试剂盒的性能。
J Microbiol Immunol Infect. 2019 Dec;52(6):920-928. doi: 10.1016/j.jmii.2019.10.009. Epub 2019 Nov 23.
3
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia.多中心评估生物梅里埃 FilmArray 肺炎Panel 快速细菌学诊断肺炎。
Clin Microbiol Infect. 2021 Sep;27(9):1308-1314. doi: 10.1016/j.cmi.2020.11.014. Epub 2020 Dec 1.
4
Evaluation of the BioFire FilmArray Pneumonia Panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens.评价生物梅里埃 FilmArray 肺炎Panel 快速检测痰和气管抽吸物标本中呼吸道细菌病原体和抗生素耐药基因。
Int J Infect Dis. 2020 Jun;95:326-331. doi: 10.1016/j.ijid.2020.03.024. Epub 2020 Mar 14.
5
The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation.Biofire® Filmarray® Pneumonia Plus 检测 panel 在 COVID-19 时代对机械通气患者下呼吸道感染的管理:一项诊断和成本效益评估。
Diagn Microbiol Infect Dis. 2023 Feb;105(2):115847. doi: 10.1016/j.diagmicrobio.2022.115847. Epub 2022 Nov 2.
6
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital's Five-Month Experience.采用多重 PCR 检测方法对 COVID-19 危重症患者细菌性肺炎的诊断与治疗:意大利某大型医院五个月的经验。
Microbiol Spectr. 2021 Dec 22;9(3):e0069521. doi: 10.1128/Spectrum.00695-21. Epub 2021 Nov 10.
7
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel.重症监护病房 COVID-19 患者的呼吸道细菌合并感染:传统培养与 BioFire FilmArray 肺炎 Plus 检测 panel 的比较。
J Microbiol Methods. 2021 Jul;186:106259. doi: 10.1016/j.mimet.2021.106259. Epub 2021 May 29.
8
Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectional study from South Africa.南非一项前瞻性横断面研究:比较生物梅里埃 FilmArray Pneumonia plus 检测试剂盒与常规方法对下呼吸道标本中细菌鉴定的实验室评估。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115236. doi: 10.1016/j.diagmicrobio.2020.115236. Epub 2020 Oct 10.
9
Potential Impact of Rapid Molecular Microbiologic Diagnosis for Mechanically Ventilated Children in Intensive Care With Suspected Pneumonia.快速分子微生物学诊断对重症监护病房中疑似肺炎的机械通气儿童的潜在影响。
Pediatr Infect Dis J. 2025 Apr 1;44(4):371-375. doi: 10.1097/INF.0000000000004629. Epub 2024 Nov 11.
10
Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.采用 FilmArray Pneumonia Panel Plus 快速鉴定重症监护病房住院患者呼吸道样本中的细菌。
Int J Infect Dis. 2021 Jul;108:568-573. doi: 10.1016/j.ijid.2021.05.074. Epub 2021 Jun 1.

引用本文的文献

1
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.快速多重分子综合征检测板在重症患者感染临床管理中的作用:一份专家意见文件。
Crit Care. 2024 Dec 30;28(1):440. doi: 10.1186/s13054-024-05224-3.

本文引用的文献

1
Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing: A Randomized Clinical Trial.症状分子检测在社区获得性肺炎中的诊断管理:一项随机临床试验。
JAMA Netw Open. 2024 Mar 4;7(3):e240830. doi: 10.1001/jamanetworkopen.2024.0830.
2
The diagnostic utility of microscopic quality assessment of sputum samples in the era of rapid syndromic PCR testing.快速综合征聚合酶链反应检测时代痰标本显微镜质量评估的诊断效用
Microbiol Spectr. 2023 Sep 29;11(5):e0300223. doi: 10.1128/spectrum.03002-23.
3
The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation.
Biofire® Filmarray® Pneumonia Plus 检测 panel 在 COVID-19 时代对机械通气患者下呼吸道感染的管理:一项诊断和成本效益评估。
Diagn Microbiol Infect Dis. 2023 Feb;105(2):115847. doi: 10.1016/j.diagmicrobio.2022.115847. Epub 2022 Nov 2.
4
Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients.分子表型诊断对危重症肺炎患者管理的影响。
Microbiol Spectr. 2022 Oct 26;10(5):e0161622. doi: 10.1128/spectrum.01616-22. Epub 2022 Sep 26.
5
Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial.分子即时检测在 ICU 肺炎患者中改善了下呼吸道病原体的安全降阶梯治疗:一项随机对照试验的结果。
J Infect. 2022 Dec;85(6):625-633. doi: 10.1016/j.jinf.2022.09.003. Epub 2022 Sep 9.
6
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital's Five-Month Experience.采用多重 PCR 检测方法对 COVID-19 危重症患者细菌性肺炎的诊断与治疗:意大利某大型医院五个月的经验。
Microbiol Spectr. 2021 Dec 22;9(3):e0069521. doi: 10.1128/Spectrum.00695-21. Epub 2021 Nov 10.
7
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).国际 ERS/ESICM/ESCMID/ALAT 医院获得性肺炎和呼吸机相关性肺炎管理指南:欧洲呼吸学会 (ERS)、欧洲重症监护医学学会 (ESICM)、欧洲临床微生物学和传染病学会 (ESCMID) 和拉丁美洲胸科协会 (ALAT) 医院获得性肺炎 (HAP)/呼吸机相关性肺炎 (VAP) 管理指南。
Eur Respir J. 2017 Sep 10;50(3). doi: 10.1183/13993003.00582-2017. Print 2017 Sep.
8
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.成人医院获得性肺炎和呼吸机相关性肺炎的管理:美国感染病学会和美国胸科学会2016年临床实践指南
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
9
How recent advances in molecular tests could impact the diagnosis of pneumonia.分子检测的最新进展如何影响肺炎的诊断。
Expert Rev Mol Diagn. 2016;16(5):533-40. doi: 10.1586/14737159.2016.1156536. Epub 2016 Mar 7.
10
Comparison of six different criteria for judging the acceptability of sputum specimens.六种判断痰标本可接受性的不同标准的比较。
J Clin Microbiol. 1982 Oct;16(4):627-31. doi: 10.1128/jcm.16.4.627-631.1982.